Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay

Makito Tanaka; Yoshiyuki Takahashi; Yin Yan Xu; Nao Yoshida; Ayami Yoshimi; Itzel Bustos Villalobos; Asahito Hama; Nobuhiro Nishio; Hirokazu Hidaka; Yue Wang; Hiroshi Yagasaki; Seiji Kojima

doi:10.1016/j.leukres.2007.11.016

Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by ³H-thymidine assay

Makito Tanaka, Yoshiyuki Takahashi, Yin Yan Xu, Nao Yoshida, Ayami Yoshimi, Itzel Bustos Villalobos, Asahito Hama, Nobuhiro Nishio, Hirokazu Hidaka, Yue Wang, Hiroshi Yagasaki, Seiji Kojima

Research output: Contribution to journal › Article › peer-review

3 Citations (Scopus)

Abstract

Recent molecular studies have revealed that the GM-CSF/RAS signaling pathway plays a central role in the pathogenesis of juvenile myelomonocytic leukemia (JMML). CFU-GM colony assay is an important test for GM-CSF hypersensitivity in patients with JMML, but requires specific skills. We established a simple and easy quantification method to test GM-CSF hypersensitivity, using a ³H-thymidine assay. With this quantification method, JMML patients with RAS mutations showed significantly higher GM-CSF sensitivity than JMML patients with PTPN11 mutations. This method will be useful not only in the diagnosis of JMML, but also to evaluate the difference of GM-CSF sensitivity among patients.

Original language	English
Pages (from-to)	1036-1042
Number of pages	7
Journal	Leukemia Research
Volume	32
Issue number	7
DOIs	https://doi.org/10.1016/j.leukres.2007.11.016
Publication status	Published - 01-07-2008
Externally published	Yes

All Science Journal Classification (ASJC) codes

Hematology
Oncology
Cancer Research

Access to Document

10.1016/j.leukres.2007.11.016

Fingerprint Dive into the research topics of 'Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by <sup>3</sup>H-thymidine assay'. Together they form a unique fingerprint.

Cite this

Tanaka, M., Takahashi, Y., Xu, Y. Y., Yoshida, N., Yoshimi, A., Villalobos, I. B., Hama, A., Nishio, N., Hidaka, H., Wang, Y., Yagasaki, H., & Kojima, S. (2008). Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by ³H-thymidine assay. Leukemia Research, 32(7), 1036-1042. https://doi.org/10.1016/j.leukres.2007.11.016

Tanaka, Makito ; Takahashi, Yoshiyuki ; Xu, Yin Yan ; Yoshida, Nao ; Yoshimi, Ayami ; Villalobos, Itzel Bustos ; Hama, Asahito ; Nishio, Nobuhiro ; Hidaka, Hirokazu ; Wang, Yue ; Yagasaki, Hiroshi ; Kojima, Seiji. / Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by ³H-thymidine assay. In: Leukemia Research. 2008 ; Vol. 32, No. 7. pp. 1036-1042.

@article{a6e42956767544e49800dc37b35219ea,

title = "Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay",

abstract = "Recent molecular studies have revealed that the GM-CSF/RAS signaling pathway plays a central role in the pathogenesis of juvenile myelomonocytic leukemia (JMML). CFU-GM colony assay is an important test for GM-CSF hypersensitivity in patients with JMML, but requires specific skills. We established a simple and easy quantification method to test GM-CSF hypersensitivity, using a 3H-thymidine assay. With this quantification method, JMML patients with RAS mutations showed significantly higher GM-CSF sensitivity than JMML patients with PTPN11 mutations. This method will be useful not only in the diagnosis of JMML, but also to evaluate the difference of GM-CSF sensitivity among patients.",

author = "Makito Tanaka and Yoshiyuki Takahashi and Xu, {Yin Yan} and Nao Yoshida and Ayami Yoshimi and Villalobos, {Itzel Bustos} and Asahito Hama and Nobuhiro Nishio and Hirokazu Hidaka and Yue Wang and Hiroshi Yagasaki and Seiji Kojima",

year = "2008",

month = jul,

day = "1",

doi = "10.1016/j.leukres.2007.11.016",

language = "English",

volume = "32",

pages = "1036--1042",

journal = "Leukemia Research",

issn = "0145-2126",

publisher = "Elsevier Limited",

number = "7",

}

Tanaka, M, Takahashi, Y, Xu, YY, Yoshida, N, Yoshimi, A, Villalobos, IB, Hama, A, Nishio, N, Hidaka, H, Wang, Y, Yagasaki, H & Kojima, S 2008, 'Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by ³H-thymidine assay', Leukemia Research, vol. 32, no. 7, pp. 1036-1042. https://doi.org/10.1016/j.leukres.2007.11.016

Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by ³H-thymidine assay. / Tanaka, Makito; Takahashi, Yoshiyuki; Xu, Yin Yan; Yoshida, Nao; Yoshimi, Ayami; Villalobos, Itzel Bustos; Hama, Asahito; Nishio, Nobuhiro; Hidaka, Hirokazu; Wang, Yue; Yagasaki, Hiroshi; Kojima, Seiji.

In: Leukemia Research, Vol. 32, No. 7, 01.07.2008, p. 1036-1042.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Quantification of granulocyte-macrophage colony-stimulating factor hypersensitivity in juvenile myelomonocytic leukemia by 3H-thymidine assay

AU - Tanaka, Makito

AU - Takahashi, Yoshiyuki

AU - Xu, Yin Yan

AU - Yoshida, Nao

AU - Yoshimi, Ayami

AU - Villalobos, Itzel Bustos

AU - Hama, Asahito

AU - Nishio, Nobuhiro

AU - Hidaka, Hirokazu

AU - Wang, Yue

AU - Yagasaki, Hiroshi

AU - Kojima, Seiji

PY - 2008/7/1

Y1 - 2008/7/1

N2 - Recent molecular studies have revealed that the GM-CSF/RAS signaling pathway plays a central role in the pathogenesis of juvenile myelomonocytic leukemia (JMML). CFU-GM colony assay is an important test for GM-CSF hypersensitivity in patients with JMML, but requires specific skills. We established a simple and easy quantification method to test GM-CSF hypersensitivity, using a 3H-thymidine assay. With this quantification method, JMML patients with RAS mutations showed significantly higher GM-CSF sensitivity than JMML patients with PTPN11 mutations. This method will be useful not only in the diagnosis of JMML, but also to evaluate the difference of GM-CSF sensitivity among patients.

AB - Recent molecular studies have revealed that the GM-CSF/RAS signaling pathway plays a central role in the pathogenesis of juvenile myelomonocytic leukemia (JMML). CFU-GM colony assay is an important test for GM-CSF hypersensitivity in patients with JMML, but requires specific skills. We established a simple and easy quantification method to test GM-CSF hypersensitivity, using a 3H-thymidine assay. With this quantification method, JMML patients with RAS mutations showed significantly higher GM-CSF sensitivity than JMML patients with PTPN11 mutations. This method will be useful not only in the diagnosis of JMML, but also to evaluate the difference of GM-CSF sensitivity among patients.

UR - http://www.scopus.com/inward/record.url?scp=41949113836&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=41949113836&partnerID=8YFLogxK

U2 - 10.1016/j.leukres.2007.11.016

DO - 10.1016/j.leukres.2007.11.016

M3 - Article

C2 - 18164384

AN - SCOPUS:41949113836

VL - 32

SP - 1036

EP - 1042

JO - Leukemia Research

JF - Leukemia Research

SN - 0145-2126

IS - 7